The cost-utility of intraoperative tranexamic acid in adult spinal deformity patients undergoing long posterior spinal fusion.
Miguel A Cartagena-ReyesJuan A Silva-AponteGabriel I Nazario-FerrerGregory A BenesAnanya ChoudharyMicheal RaadSteven M FrankFarah N MusharbashCarlos Ortiz-BabiloniaPublished in: Spine deformity (2024)
Use of intraoperative TXAs is a cost-effective strategy to reduce overall perioperative costs related to post-operative blood transfusions. Administration of intraoperative TXA should be considered for long fusions in ASD population when not explicitly contra-indicated due to patient factors.